Yuflyma is the ninth biosimilar to adalimumab to receive FDA approval.

Published Date: 27 May 2023

Additionally, the manufacturer Celltrion is asking the FDA for an interchangeability designation, which is anticipated to be granted in the fourth quarter of 2024.

Read Full News

Latest News

Aug 21 2026 This Week in Cardiology

Mechanical CPR devices, the dangers of AF performance measures, two scholarly articles on CLOSURE and CHAMPION, and a little ESC preview are the topics John Mandrola, MD, discusses in this week’s podcast.

NHS 10-Year Plan Risks ‘Patient Harm at Unprecedented Scale’

Compliance with statutory digital clinical safety standards is not routinely monitored or enforced in the NHS, placing patients at risk, experts warn.

10 Gynecologic Emergencies: When and How to Manage Them

From ectopic pregnancy to ovarian torsion, these emergencies can present with overlapping symptoms that require rapid recognition, assessment and management.

Analysis-Moderna, Merck Breakthrough Could Usher in Wave Of Cancer Vaccines

Merck and Moderna's success with a personalized cancer vaccine designed to keep melanoma at bay opens a new avenue of treatment that doctors hope will work against many...

Paediatricians Urge Tighter Rules on Vape Flavours

Paediatricians say the Tobacco and Vapes Act is not enough and want the government to restrict vape flavours, not just their names.

Born Too Late? Young Doctors Speak Out on the ‘Golden Age’

They entered medicine amid COVID, prior authorizations, corporate ownership, and collapsing public trust. Some mourn what disappeared. Others wonder whose golden age it was.

Todays Updates

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Can a Betting Market Offer Hope to a Cancer Patient?

As we embrace the power of collective knowledge, we must remember that numbers are just numbers

Rewriting the Future of Medicine; Cancer Cost Burden; Mental Health Toll of Cancer

News, features, and commentary about cancer-related issues

Biden's Bedtime Cancer Symptom; Top Cancer Hospitals; FDA Panel to Review MCED Test

News, features, and commentary about cancer-related issues

Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML

"This specific formulation of daunorubicin and cytarabine is not the right choice," experts said

Post-Transplant Outcomes in Hodgkin Lymphoma Improved Over Time

Improvements primarily driven by reduction in incidence of relapse

Todays Updates

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Can a Betting Market Offer Hope to a Cancer Patient?

As we embrace the power of collective knowledge, we must remember that numbers are just numbers

Rewriting the Future of Medicine; Cancer Cost Burden; Mental Health Toll of Cancer

News, features, and commentary about cancer-related issues

Biden's Bedtime Cancer Symptom; Top Cancer Hospitals; FDA Panel to Review MCED Test

News, features, and commentary about cancer-related issues

Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML

"This specific formulation of daunorubicin and cytarabine is not the right choice," experts said

Post-Transplant Outcomes in Hodgkin Lymphoma Improved Over Time

Improvements primarily driven by reduction in incidence of relapse

Latest News

Mechanical CPR devices, the dangers of AF performance measures, two scholarly articles on CLOSURE and CHAMPION, and a little ESC preview are the topics John Mandrola, MD, discusses in this week’s podcast.

Compliance with statutory digital clinical safety standards is not routinely monitored or enforced in the NHS, placing patients at risk, experts warn.

From ectopic pregnancy to ovarian torsion, these emergencies can present with overlapping symptoms that require rapid recognition, assessment and management.

Merck and Moderna's success with a personalized cancer vaccine designed to keep melanoma at bay opens a new avenue of treatment that doctors hope will work against many...

Paediatricians say the Tobacco and Vapes Act is not enough and want the government to restrict vape flavours, not just their names.

They entered medicine amid COVID, prior authorizations, corporate ownership, and collapsing public trust. Some mourn what disappeared. Others wonder whose golden age it was.

News All Time

Moderna, Merck Vaccine Cuts Recurrence and Spread Of Melanoma, Raising New Treatment Hope

Moderna and Merck said on Wednesday that a personalized mRNA cancer vaccine reduced the risk of recurrence and spread of melanoma in a late-stage trial, a major success in a...

Deep Dive: APOC3 Inhibitors: Tryngolza vs Redemplo

Olezarsen now covers severe hypertriglyceridemia; plozasiran remains FCS-only. Neha Pagidipati, MD, on what the split means for practice.

Viral Spicy Food Challenges: Have They Become Too Risky?

Extreme spicy food challenges can cause gastrointestinal symptoms and, in rare cases, severe reactions, prompting health authorities to urge greater caution in adolescents.

Are We Training Doctors for the Systems They'll Inherit?

Medical exchanges with five health systems showed one medical student that the answer is no.

Hospitalists Face a Growing Risk for Decision-Making Fatigue

A combination of large patient load and ‘a million decisions a day’ can lead to poorer outcomes.

How Pharmacists Can Strengthen Drug Safety Monitoring

Pharmacists play a key role in spotting suspected adverse reactions early, even when the link to a medicine is uncertain.

Congenital Ichthyosis Tied to Risk for Allergic Disorders

Patients with congenital ichthyosis may have significantly higher rates of allergic rhinitis, food allergy, and allergic asthma than those in the general population, a survey finds.

Does CKD Severity Predict Adverse ICU Outcomes?

Among patients in the ICU, the presence and severity of chronic kidney disease are tied to a higher risk for mortality; among those who receive maintenance dialysis, the risk is comparatively lower.

Gram-Negative Bacteria Lead Pediatric Cancer BSIs

Gram-negative bacteria account for nearly 70% of bloodstream infections in pediatric oncology patients, with nonsusceptibility rates of some organisms to antibiotics increasing.

Mastectomy Preserves Ventriculoperitoneal Shunt in Woman

A woman with breast cancer underwent mastectomy near a ventriculoperitoneal shunt, which was preserved through careful imaging, planning, and sharp dissection.

Argenx Drug Vyvgart Meets Goal in Autoimmune Myositis Study

Belgian-Dutch immunology company argenx said on Monday its autoimmune drug Vyvgart met the primary endpoint in a late-stage study in autoimmune myositis, ⁠potentially...

Medical Therapy Reduces Nasal Discharge in CRS

Medical therapy significantly reduces nasal discharge symptoms in chronic rhinosinusitis, with benefits observed in both patients with nasal polyps and those without.

Antioxidants in Vitiligo: Experts Support Select Ingredients

Experts say some antioxidants can improve vitiligo with or without phototherapy, but ingredients backed by evidence remain limited.

Cannabis Use May Increase Fall Risk in Adults With HIV

Among adults living with HIV, cannabis use is associated with an increased risk for falls — but the link weakens after accounting for other substance use and medications.

VNS for RA a Year After Approval: Where Do Things Stand?

A year after approval of the first VNS device for rheumatoid arthritis, many patients are interested and providers in eight states are able to offer the device, but insurers are hesitating.

SLE Linked to Increased Risk for Venous Thromboembolism

Systemic lupus erythematosus is associated with an increased risk for venous thromboembolism, with the highest risk occurring in the first year after diagnosis.

Recommended News For You

Survival rates for incurable larynx cancer investigated for first time

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona

New imaging technique identifies glioblastoma patients who would benefit from immunotherapy

Young adults who are obese are at risk for 17 different types of cancer in the future.

Healthy weight loss could lower your odds for cancer

Kekoa Taparra, a native Hawaiian physician-scientist, is becoming well-known.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

Recommended Articles For You

Case Learning from Acquired Platelet Function Disorders 

Strategic Applications in Hematology in Clinical Decision-Making 

Beyond the Cure: The Emerging Role of Tissue-Agnostic Therapies in Palliative Oncology 

Progressive Perspectives in Oncology Across Clinical Settings 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Studies have shown that physical activity prevents cancer in patients who have been treated for cancer in the past.

2.

Glioblastoma treatment breakthrough shows promise

3.

Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?

4.

Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors

5.

Small-Town Patients Face Big Hurdles as Rural Hospitals Cut Cancer Care

1.

The Latest Research on Wiskott Aldrich Syndrome 

2.

Uncovering the Hidden Signs: How to Recognize the Early Symptoms of Colon Cancer

3.

Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care

4.

Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy 

5.

Bispecific Antibodies in Hematologic Malignancies: Mechanisms, Clinical Applications, and Future Directions

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

2.

Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment

3.

Efficient Management of First line ALK-rearranged NSCLC - Part V

4.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

5.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot